-
61
Innovation Inspired by COVID: A Virtual Treatment Program for Patients With Mild Cognitive Impairment at Mayo Clinic
Published 2021-10-01“…Mayo Clinic Proceedings: Innovations, Quality & Outcomes…”
Get full text
Article -
62
P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE
Published 2023-08-01Get full text
Article -
63
-
64
The New Mayo Clinic Risk Score Characteristics in Acute Coronary Syndrome in Patients following Percutaneous Coronary Intervention
Published 2018-02-01“…The present study was aimed at determining the risk stratification of mortality and MACE in post-PCI patients at the intensive cardiac care unit of Cipto Mangunkusumo Hospital (CMH) using 7 variables of the New Mayo Clinic Risk Score (NMCRS). Method: This cross-sectional study drew upon secondary data gathered from the medical records of 313 patients that underwent PCI at the intensive cardiac care unit (ICCU) of CMH between August 1st, 2013, and August 31st, 2014. …”
Get full text
Article -
65
-
66
Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic
Published 2014-02-01“…David T Eton,1,2 Timothy J Beebe,1,2 Philip T Hagen,3 Michele Y Halyard,4 Victor M Montori,1,5 James M Naessens,1,2 Jeff A Sloan,6 Carrie A Thompson,7 Douglas L Wood1,81Division of Heath Care Policy and Research, Department of Health Sciences Research, 2Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, 3Department of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, MN, 4Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, 5Knowledge and Evaluation Research Unit, 6Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, 7Division of Hematology, Department of Medicine, 8Center for Innovation, Mayo Clinic, Rochester, MN, USAAbstract: Patient-reported outcomes (PROs) capture how patients perceive their health and their health care; their use in clinical research is longstanding. …”
Get full text
Article -
67
A Case Series of Minimally Invasive Robotic-Assisted Resection of Cardiac Papillary Fibroelastoma: The Mayo Clinic Experience
Published 2024-04-01“…Mayo Clinic Proceedings: Innovations, Quality & Outcomes…”
Get full text
Article -
68
No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study
Published 2021-02-01“…Paul Y Takahashi,1 Euijung Ryu,2 Suzette J Bielinski,3 Matthew Hathcock,2 Gregory D Jenkins,2 James R Cerhan,3 Janet E Olson3 1Division of Community Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA; 2Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; 3Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USACorrespondence: Paul Y TakahashiDivision of Community Internal Medicine, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USATel +1-507-284-2511Fax +1-507-266-2297Email Takahashi.paul@mayo.eduBackground: The use of pharmacogenomics data is increasing in clinical practice. …”
Get full text
Article -
69
-
70
Equity in healthcare and workforce: Outcomes from the Mayo Clinic RISE for Equity: Reflect, Inspire, Strengthen & Empower conference
Published 2024-01-01“…Objective: To evaluate the impact of the Mayo Clinic Reflect, Inspire, Strengthen and Empower (RISE) for Equity national conference on participant healthcare professionals’ knowledge, skills, and attitudes (KSA) related to diversity, equity, and inclusion (DEI) and anti-racism. …”
Get full text
Article -
71
Practical Considerations for and Outcomes of Interfacility ECMO Transfer of Patients With COVID-19 During a Pandemic: Mayo Clinic Experience
Published 2021-04-01“…Mayo Clinic Proceedings: Innovations, Quality & Outcomes…”
Get full text
Article -
72
Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank
Published 2023-04-01“…Therefore, we determined whether ceramide levels are associated with the rapid development of MM.Design Retrospective cohort study.Setting Mayo Clinic Biobank.Participants 1809 persons in the Mayo Clinic Biobank ≥65 years without MM at the time of enrolment, and with ceramide levels assayed from stored plasma.Primary outcome measure Persons were followed for a median of 5.7 years through their medical records to identify new diagnoses of 20 chronic conditions. …”
Get full text
Article -
73
-
74
The Mayo Clinic Florida Microdosimetric Kinetic Model of Clonogenic Survival: Application to Various Repair-Competent Rodent and Human Cell Lines
Published 2022-10-01“…The relative biological effectiveness (RBE) calculations used during the planning of ion therapy treatments are generally based on the microdosimetric kinetic model (MKM) and the local effect model (LEM). The Mayo Clinic Florida MKM (MCF MKM) was recently developed to overcome the limitations of previous MKMs in reproducing the biological data and to eliminate the need for ion-exposed in vitro data as input for the model calculations. …”
Get full text
Article -
75
Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience
Published 2018-03-01“…Mayo Clinic Proceedings: Innovations, Quality & Outcomes…”
Get full text
Article -
76
Severity of illness and risk of mortality in Mayo Clinic’s virtual hybrid advanced care at home program: a retrospective cohort study
Published 2023-03-01“…Abstract Background In July 2020, Mayo Clinic launched Advanced Care at Home (ACH), a high-acuity virtual hybrid hospital-at-home model (HaH) of care at Mayo Clinic Florida and Northwest Wisconsin, an urban destination medical center and a rural community practice respectively. …”
Get full text
Article -
77
Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases
Published 2022-11-01“…By contrast, the 2022 International Consensus Classification (ICC) includes PEL under a broader category of “acute myeloid leukemia with mutated TP53”. We identified 41 Mayo Clinic cases of PEL (mean age 66 years, range 27–86; 71% males) and provide a comprehensive account of bone marrow morphology, immunophenotype, cytogenetic and mutation profiles. …”
Get full text
Article -
78
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
Published 2023-06-01“…To better serve these patients, the Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD) was created under the auspices of the Center for Individualized Medicine (CIM) aiming to integrate genomics into subspecialty practice including targeted genetic testing, research, and education. …”
Get full text
Article -
79
-
80